Back

An Enantioselective Chemical Probe for Chikungunya nsP2 Helicase with Antialphaviral Activity

Ramalingam, M. B.; Oh, H. J.; Sears, J. D.; Chen, C.-H.; Vala, A.; Liu, S.; Talbot, K. M.; Hossain, M. A.; Brown, P. J.; Houliston, S.; Garcia Perez, J.; Li, F.; Amare, M. G.; Halfmann, P.; Smith, J.; Hirsch, A.; Arrowsmith, C. H.; Halabelian, L.; Vargason, A. M.; Counago, R. M.; Arnold, J. J.; Cameron, C. E.; Moorman, N. J.; Heise, M. T.; Willson, T. M.

2025-04-27 pharmacology and toxicology
10.1101/2025.04.24.650479 bioRxiv
Show abstract

Chikungunya virus (CHIKV) replication relies on the multifunctional nsP2 protein, making it an attractive target for antiviral drug discovery. Here, we report the resolution of oxaspiropiperidine 1, a first-in-class inhibitor of the CHIKV nsP2 RNA helicase (nsP2hel), into its constitutive enantiomers and characterization of their antiviral activity. The enantiomer (R)-1 exhibited potent inhibition of viral replication, nsP2hel ATPase activity, and dsRNA unwinding, while the (S)-1 enantiomer was >100-fold less active. The (R)-1 enantiomer also demonstrated high selectivity for CHIKV over other RNA viruses and for nsP2hel over other RNA helicases. Direct binding of (R)-1 to nsP2hel protein was confirmed by 19F NMR. Biophysical and structural studies revealed conformational polymorphism in the spirocyclic scaffold of (R)-1, suggesting a potential role of thermal mobility of the ligand in allosteric inhibition of nsP2hel. Collectively, these findings designate (R)-1 (RA-NSP2-1) as a high-quality chemical probe and (S)-1 (RA-NSP2-1N) as a negative control for probing the biology of alphavirus RNA helicases.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Angewandte Chemie International Edition
81 papers in training set
Top 0.1%
22.5%
2
ACS Central Science
66 papers in training set
Top 0.1%
9.2%
3
ChemMedChem
15 papers in training set
Top 0.1%
9.2%
4
Journal of Medicinal Chemistry
68 papers in training set
Top 0.1%
8.4%
5
Journal of the American Chemical Society
199 papers in training set
Top 0.8%
8.2%
50% of probability mass above
6
Nature Communications
4913 papers in training set
Top 35%
4.3%
7
Bioorganic & Medicinal Chemistry Letters
10 papers in training set
Top 0.1%
4.3%
8
Nucleic Acids Research
1128 papers in training set
Top 6%
3.6%
9
Acta Pharmaceutica Sinica B
11 papers in training set
Top 0.2%
2.7%
10
Cell Chemical Biology
81 papers in training set
Top 1%
2.6%
11
ACS Chemical Biology
150 papers in training set
Top 0.6%
2.6%
12
ACS Medicinal Chemistry Letters
16 papers in training set
Top 0.2%
2.1%
13
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 35%
1.5%
14
ACS Pharmacology & Translational Science
40 papers in training set
Top 0.5%
1.5%
15
European Journal of Medicinal Chemistry
16 papers in training set
Top 0.2%
0.9%
16
Pharmacology Research & Perspectives
11 papers in training set
Top 0.2%
0.9%
17
Advanced Science
249 papers in training set
Top 16%
0.9%
18
Nature Chemistry
34 papers in training set
Top 0.7%
0.9%
19
eLife
5422 papers in training set
Top 58%
0.7%
20
Nature Chemical Biology
104 papers in training set
Top 3%
0.7%
21
Journal of Chemical Information and Modeling
207 papers in training set
Top 3%
0.7%
22
Viruses
318 papers in training set
Top 6%
0.6%